Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2017-05-03

Clinical Trial Update: UVX as an Adjuvant in the Treatment of Fungal Keratitis [NA]

View source ↗

Summary

Clinical trial update indicates UVX used as an adjuvant in the treatment of fungal keratitis, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UVX

Snippet

Sponsor: Farabi Eye Hospital | Conditions: Treatment | NA | Status: UNKNOWN